Targeting IL-17 and TH17 cells in chronic inflammation
The DOI matches its Crossref record; 169 of the 169 references it cites were found in a registry or an index.
Abstract
The key role of interleukin-17 (IL-17) and T helper 17 (T(H)17) cells in tissue inflammation, autoimmunity and host defence led to the experimental targeting of these molecules in mouse models of diseases as well as in clinical settings. Moreover, the demonstration that IL-17 and T(H)17 cells contribute to local and systemic aspects of disease pathogenesis, as well as the finding that the IL-17-T(H)17 cell pathway is regulated by IL-23, prompted the identification of inhibitors. These inhibitors include biotechnology products that target IL-23 as well as the leading member of the IL-17 family, IL-17A, and one of its receptors, IL-17 receptor A. Several clinical trials of these inhibitors are underway, and positive results have been obtained in psoriasis, rheumatoid arthritis and ankylosing spondylitis. This Review focuses on the current knowledge of the IL-17-T(H)17 cell pathway to better understand the positive as well as potential negative consequences of targeting them.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Abs against IL-17/IL-17RA are in clinical trials for other autoimmune conditions [55].”
From The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney (2016) · cites this paper as [55]
Citations
Cites
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605
Transforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
Zheng, Y., Danilenko, D. M., Valdez, P., Kasman, I., Eastham-Anderson, J., Wu, J., & Ouyang, W. (2007) · Nature · doi:10.1038/nature05505 · Cited by 1,862
Aggarwal, S., Ghilardi, N., Xie, M.-H., de Sauvage, F. J., & Gurney, A. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207577200 · Cited by 1,847
Lock, C., Hermans, G., Pedotti, R., Brendolan, A., Schadt, E., Garren, H., Langer-Gould, A., Strober, S., Cannella, B., Allard, J., et al. (2002) · Nature Medicine · doi:10.1038/nm0502-500 · Cited by 1,669
Research works printed but not linked: 1
- Baeten, D. et al. The anti-IL17A monoclonal antibody secukinumab (AIN457) showed good safety and efficacy in the treatment of active ankylosing spondylitis. Arthritis Rheum. 62, Abstract L3847 (2010).
Cited by
Items 801–900 of 1,000
Eladl, O. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115257 · Cited by 14
Possible Relation between Vitamin D and Interleukin-17 in the Pathogenesis of Lichen Planus
Mahmoud, S. B., Anwar, M. K., Shaker, O. G., & Sharkawy, D. A. E. (2020) · Dermatology · doi:10.1159/000510539 · Cited by 14
Medical progress: Stem cells as a new therapeutic strategy for COVID-19
Musiał, C., & Górska‐Ponikowska, M. (2021) · Stem Cell Research · doi:10.1016/j.scr.2021.102239 · Cited by 16
IL‑17F promotes osteoblastic osteogenesis via the MAPK/ERK1/2 signaling pathway
Zhang, N., Cui, M., Liu, X., Yu, L., Zhao, X., Cao, L., & Ji, Y. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10486 · Cited by 15
“IL‐17A and IL‐17F are dominant proinflammatory cytokines, exhibiting the highest degree of sequence homology (7,8).”
BackgroundТодосенко, Н. М., Vulf, M. A., Yurova, K. A., Хазиахматова, О. Г., Mikhailova, L. V., & Litvinova, L. S. (2021) · Biomedicines · doi:10.3390/biomedicines9121750 · Cited by 14
“High expression of CD39 in Th17 lymphocytes was associated with low IL-17A production in patients with AIZ [79,80].”
BackgroundFarzaneh, R., Khabbazi, A., Soltani‐Zangbar, M. S., Abbasian, S., Mahdavi, A. M., Motavalli, R., & Yousefi, M. (2022) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2022.2026380 · Cited by 17
Wu, Z., & Bi, Y. (2022) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24130 · Cited by 14
Zhang, J., Cao, G., Tian, L., Hou, J., Zhang, Y., Xu, H., Wang, M., Jia, Q., Wang, L., & Yang, H. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154578 · Cited by 14
Blood immunological profile of abdominal aortic aneurysm based on autoimmune injury
Huanggu, H., Yang, D., & Zheng, Y. (2022) · Autoimmunity Reviews · doi:10.1016/j.autrev.2022.103258 · Cited by 15
Neutrophilia in severe asthma is reduced in Ormdl3 overexpressing mice
James, B. N., Weigel, C., Green, C. D., Brown, R. D. R., Palladino, E. N. D., Tharakan, A., Milstien, S., Proia, R. L., Martin, R., & Spiegel, S. (2023) · The FASEB Journal · doi:10.1096/fj.202201821r · Cited by 14
Lin, H.-C., Chang, H.-M., Hung, Y., Chang, R., Chen, H., & Wei, J. C. (2023) · Arthritis Research & Therapy · doi:10.1186/s13075-023-02999-8 · Cited by 14
“Second, interleukin-17 (IL-17) and Th17 which are known to participate in inflammation [24] also play important roles in autoimmune diseases, including HT and SLE [25, 26].”
BackgroundImmunotherapy targeting plasma ASM is protective in a mouse model of Alzheimer’s disease
Choi, B. J., Park, M. H., Park, K. H., Han, W. H., Yoon, H. J., Jung, H. Y., Hong, J. Y., Chowdhury, M. R., Kim, K. Y., Lee, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37316-z · Cited by 15
The role of IL-17 in lung cancer growth
Liu, L., Liu, R., Wei, C., Li, D., & Gao, X. (2023) · Cytokine · doi:10.1016/j.cyto.2023.156265 · Cited by 14
Bimekizumab for the treatment of psoriatic arthritis
Tanaka, Y., & Shaw, S. (2023) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2023.2277266 · Cited by 14
“The complete clinical relevance of IL-23 independent pathways of IL-17 production in psoriatic disease is unknown [7,10,15].”
BackgroundÅkefeldt, S. O., Ismail, M. B., Valentin, H., Aricò, M., Henter, J., & Delprat, C. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/701305 · Cited by 14
“and BCL2A1 gene expressions results in recruitment and stabilization of myeloid cells of the immune system [27, 28].”
BackgroundNKT cells are important mediators of hepatic ischemia-reperfusion injury
Richards, J. A., Wigmore, S. J., Anderton, S. M., & Howie, S. (2017) · Transplant Immunology · doi:10.1016/j.trim.2017.08.002 · Cited by 16
“Interleukin-17 (IL-17) has been linked with the pathology of a number of autoimmune diseases [45] and is important in neutrophil chemotaxis [46].”
BackgroundImmune pathogenesis of psoriasis
Khairutdinov, V. R., Belousova, I. E., & Samtsov, A. V. (2016) · Vestnik dermatologii i venerologii · doi:10.25208/0042-4609-2016-92-4-20-26 · Cited by 17
Wei, C.-Y., Lin, J., Wang, Y.-T., Huang, J., Wei, J. C., & Chiou, J. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102482 · Cited by 14
Robert, M., Hot, A., Mifsud, F., Ndongo-Thiam, N., & Miossec, P. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01998 · Cited by 15
“For instance, the inhibition of IL-17RA, one of the subunit of the IL-17 receptor, also inhibits the antiinflammatory effect mediated by IL-25, whose receptor shares one common subunit, IL-17RC, with IL-17A (4, 21).”
BackgroundSelf-citationChlorogenic Acid Relieves the Lupus Erythematosus-like Skin Lesions and Arthritis in MRL/lpr Mice
Wang, R., Yang, X., You, S., Hao, M., Li, J., Chen, X., & Jin, J. (2022) · Pharmaceuticals · doi:10.3390/ph15111327 · Cited by 14
“Th17 cells can secrete large amounts of IL-17, a pro-inflammatory cytokine, in response to pro-inflammatory factors that contribute to the pathogenesis of many inflammatory diseases [29].”
BackgroundWu, L., Chen, Y., Zhong, S., Li, Y., Dai, X., & Di, Y. (2015) · Indian Pediatrics · doi:10.1007/s13312-015-0659-1 · Cited by 14
“IL-17, as an inflammatory factor, guides neutrophil and monocyte towards vascular wall to catalyze the reaction of inflammations and participate in the emergence of multiple self-immune diseases and inflammatory responsive diseases, for example systemic lupus erythematosus [9], systemic onset juvenile idiopathic arthr…”
BackgroundShao-Yu, Y., Niu, D., Chen, J., Li, W.-Y., Wang, X., Meng, Q.-W., Song, W.-J., Yang, Y., Wang, H., Li, R., et al. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2582944 · Cited by 16
“21,39,40 Our findings demonstrate a significantly diminished differentiation capacity of Th17 cells in FMT from antibiotic-treated mice.”
Song, M., Wang, Y., Zhou, P., Wang, J., Xu, H., & Zheng, J. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01110 · Cited by 13
Yang, C.-L., Wang, F., Luo, J., Rong, S.-J., Lu, W.-Y., Chen, Q., Xiao, J., Wang, T., Song, D.-N., Liu, J., et al. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.05.038 · Cited by 13
IFI16 promotes the progression of clear cell renal cell carcinoma through the IL6/PI3K/AKT axis
Lu, K., Zhao, Y., Yu, L., Fu, Z., Chen, Y., Kong, Y., & Li, G. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05354-w · Cited by 16
Anti-IL-17 Inhibits PINK1/Parkin Autophagy and M1 Macrophage Polarization in Rheumatic Heart Disease
Ling, B., Li, Y., Lu, C., Yang, Y., Zhang, J., Lu, Z., Huang, K., Xian, S., Yang, X., Na, N., et al. (2024) · Inflammation · doi:10.1007/s10753-024-02094-3 · Cited by 13
“Therapies targeting the IL-17 pathway have been approved for the treatment of autoimmunity with positive and effective results [33].”
You, K., Yang, L., Su, Z., Shen, J., Fan, X., Guo, Y., Yuan, Z., & Lü, H. (2024) · Biomedicines · doi:10.3390/biomedicines13010009 · Cited by 14
“Emerging evidence suggests that pro-inflammatory cytokines like IL-17/TH17 and gut microbiota are pivotal players in the progression of AS [35].”
Zhang, F., Feng, R., Tong, M., Jin, C., Zhang, S., Xu, Y., Meng, J., Yang, C., Zhang, M., & Liang, C. Y. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114959 · Cited by 14
Xu, J., Tang, Y., Shen, C., Li, K., Zhao, M., Zhou, F., Tian, S., Yu, J., Ding, Z., & Chen, Y. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115054 · Cited by 13
Traunecker, E., Gardner, R., Fonseca, J. E., Pereira, J. P., Seitz, M., Villiger, P. M., Iezzi, G., & Padovan, E. (2015) · European Journal of Immunology · doi:10.1002/eji.201445100 · Cited by 13
Aizman, E., Blacher, E., Ben‐Moshe, O., Kogan, T. V., Kloog, Y., & Mor, A. (2013) · Clinical & Experimental Immunology · doi:10.1111/cei.12235 · Cited by 13
Pathways involved in the resolution of inflammatory joint disease
Haworth, O., & Buckley, C. D. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.04.002 · Cited by 13
Cai, G., Xin, L., Wang, L., Fan, D., Liu, L., Hu, Y., Ding, N., Xu, S., Xia, G., Jin, X., et al. (2014) · Modern Rheumatology · doi:10.3109/14397595.2014.973658 · Cited by 13
Yu, Q., Shi, Y., Shu, C., Ding, X., Zhu, S., Shen, Z., & Lou, Y. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/6862073 · Cited by 20
“As the subpopulation of T helper cells, +17 cells produce IL-17 A/IL-17F and play a pivotal role in inflammation, autoimmunity, and host defense against extracellular pathogens [25, 26].”
BackgroundLiu, M., Lu, B., Fan, H., Guo, X., Du, S., Yang, D., Xu, Y., Li, Y., Che, D., Liu, Y., et al. (2021) · Mediators of Inflammation · doi:10.1155/2021/9955168 · Cited by 14
Mattsson, J., Israelsson, E., Björhall, K., Yrlid, L., Thörn, K., Thorén, A., Toledo, E. A., Jinton, L., Öberg, L., Wingren, C., et al. (2023) · Skin Health and Disease · doi:10.1002/ski2.209 · Cited by 16
“IL‐17 was also not inhibited by JAK1 inhibition as opposed to the pan‐JAK inhibitors, perhaps questioning its efficacy in diseases such as psoriasis and ankylosing spondylitis where both pan‐JAK inhibitors and anti‐IL‐17 biologicals have shown great clinical efficacy.(81) As for pan‐JAK inhibitors this was observed at…”
ResultHK3 stimulates immune cell infiltration to promote glioma deterioration
Li, S., Li, Z., Wang, X., Zhong, J., Yu, D., Chen, H., Ma, W., Liu, L., Ye, M., Shen, R., et al. (2023) · Cancer Cell International · doi:10.1186/s12935-023-03039-w · Cited by 15
“…IHC for several markers of immune cells, such as TXB21 [53], IFNG for Th1 cell [54], GATA3, IL4 for Th2 cells [55, 56], IL17, RORC for Th17 cell [57, 58] and IL2RA, FoxP3 for Treg cell [58, 59], was carried out on samples from the Hk3-OE group and NC group, and showed that Hk3-overexpressing…”
BackgroundHolloway, T. L., Rani, M., Cap, A. P., Stewart, R. M., & Schwacha, M. G. (2015) · Cytokine · doi:10.1016/j.cyto.2015.09.003 · Cited by 16
New Approaches for Studying Alcoholic Liver Disease
Xu, J., Liu, X., Gao, B., Karin, M., Tsukamoto, H., Brenner, D. A., & Kisseleva, T. (2014) · Current Pathobiology Reports · doi:10.1007/s40139-014-0053-z · Cited by 13
Pan, Y., Wang, W.-H., Huang, T.-Y., Weng, W.-H., Fang, C.-K., Chen, Y.-C., & Hwang, J. (2018) · Inflammation Research · doi:10.1007/s00011-018-1176-1 · Cited by 13
Live-stream characterization of cadmium-induced cell death using visible CdTe-QDs
Filali, S., Géloën, A., Lysenko, V., Pirot, F., & Miossec, P. (2018) · Scientific Reports · doi:10.1038/s41598-018-31077-2 · Cited by 13
Self-citation5,6,7,8-Tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine derivatives as inhibitors of full-length RORγt
Lao, C., Zhou, X., Chen, H., Wei, F., Huang, Z., & Bai, C. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.103077 · Cited by 14
Beyond type 2 cytokines in asthma - new insights from old clinical trials
Choy, D. F., & Arron, J. R. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1744567 · Cited by 14
“IL17 dependent transcription synergizes with TNFα, by stabilizing mRNAs encoding chemokines and other inflammatory mediators [72].”
BackgroundManipulating the microbiome to enhance oral tolerance in food allergy
Gonzalez-Visiedo, M., Kulis, M. D., & Markusic, D. M. (2022) · Cellular Immunology · doi:10.1016/j.cellimm.2022.104633 · Cited by 14
Study on the comorbid mechanisms of sarcopenia and late-life depression
Wu, J., Tang, J., Huang, D., Wang, Y., Zhou, E., Ru, Q., Xu, G., Chen, L., & Wu, Y. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2025.115538 · Cited by 12
“Research has shown that Th17 cells, particularly those induced by Citrobacter rodentium , exhibit strong pro-inflammatory properties[199].”
Wang, H., Huang, M., Zhu, M., Su, C., Zhang, Y., Chen, H., Jiang, Y., Wang, H., Guo, Q., & Zhang, S. (2024) · Chinese Medicine · doi:10.1186/s13020-024-00904-2 · Cited by 14
miR-155 promotes Th17 differentiation by targeting FOXP3 to aggravate inflammation in MRSA pneumonia
Tian, K., Xu, W., Mingxiao, C. H. E. N., & Deng, F. (2024) · Cytokine · doi:10.1016/j.cyto.2024.156662 · Cited by 12
Neutrophils are not the dominant interleukin‐17 producer in psoriasis
Yamanaka, K., Yamagiwa, A., Akeda, T., Kondo, M., Kakeda, M., Habe, K., Imafuku, S., Sano, S., & Mizutani, H. (2017) · The Journal of Dermatology · doi:10.1111/1346-8138.13807 · Cited by 12
Ortiz, M. A., Piedrafita, F. J., & Nefzi, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084433 · Cited by 12
“There is compelling evidence that IL-17-producing Th17 cells play a critical pathogenic role in chronic inflammation and autoimmune diseases, including multiple sclerosis, rheumatoid arthritis, inflammatory bowel disease, type I diabetes, and psoriasis [5,6], which suggested RORs as attractive targets for treating aut…”
BackgroundLevels of Pathogenic Th17 and Th22 Cells in Patients with Rheumatoid Arthritis
Vitales‐Noyola, M., Hernández-Castro, B., Alvarado‐Hernandez, D. L., Baranda, L., Bernal‐Silva, S., Abud‐Mendoza, C., Niño-Moreno, P., & González‐Amaro, R. (2022) · Journal of Immunology Research · doi:10.1155/2022/5398743 · Cited by 13
“Accordingly, the blockade of IL-17 or its receptor with therapeutic monoclonal antibodies (MoAb) has provided some unexpected results, with no significant effect in Crohn’s disease but encouraging results in multiple sclerosis [16, 17].”
BackgroundResultZhu, M., Guo, Q., Kang, H., Peng, R., Dong, Y., Zhang, Y., Wang, S., Liu, H., Zhao, H., Dong, Z., et al. (2022) · The FASEB Journal · doi:10.1096/fj.202200911r · Cited by 13
Wang, Q., Zhong, Y., Chen, N., & Chen, J. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1078984 · Cited by 12
“Clinical studies have found that Th17 cells and the proinflammatory factor IL-17 are increased in toxoplasmosis (Dutra et al., 2013; Silva et al., 2014), and IL-17 will further promote the inflammatory response and expand tissue damage after T. gondii infection (Guiton et al., 2010).”
BackgroundInfluentialRole of interleukin 17 (IL-17) in the inflammatory hypothesis of depression
Bliźniewska-Kowalska, K. M., Halaris, A. E., Gałecki, P., & Gałecka, M. (2023) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2023.100610 · Cited by 15
Benezeder, T., Bordag, N., Woltsche, J. N., Teufelberger, A. R., Perchthaler, I., Weger, W., Salmhofer, W., Gruber‐Wackernagel, A., Painsi, C., Zhan, Q., et al. (2025) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2025.05.006 · Cited by 15
The role of IL-17 in the treatment of psoriatic arthritis
Lubrano, E., & Perrotta, F. M. (2017) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2017.1327354 · Cited by 12
Osgood, J. A., & Knight, J. C. (2018) · Briefings in Functional Genomics · doi:10.1093/bfgp/ely015 · Cited by 19
“Dendritic cells are important in antigen presentation and also secrete IL23, which is thought to be a major signalling pathway in AS [110].”
BackgroundFrom bedside to bench to clinic trials: identifying new treatments for severe asthma
Mishra, A., Yao, X., & Levine, S. J. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.012070 · Cited by 12
“IL-17A, which is primarily produced by CD4+ Th17 cells, as well as by γδ T cells, natural killer (NK) cells, mast cells and neutrophils, is increased in the lungs of severe asthmatics and correlates with sputum neutrophilia (Miossec and Kolls, 2012).”
BackgroundInfluentialKulminski, A. M., Loika, Y., Huang, J., Arbeev, K. G., Bagley, O., Ukraintseva, S. V., Yashin, A. I., & Culminskaya, I. V. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00433 · Cited by 12
“The IL-17, the key cytokine produced by Th17 cells, contributes to tissue inflammation associated with extracellular matrix destruction and activates the production and function of matrix metalloproteinases (Miossec and Kolls, 2012).”
BackgroundMunjita, S. M., Samutela, M., Ndashe, K., & Munsaka, S. M. (2020) · Pan African Medical Journal · doi:10.11604/pamj.supp.2020.35.2.23267 · Cited by 13
“This has been linked to high expression of Interleukin 6 (IL-6) and Interleukin 23 (IL-23) that accelerate inflammation and promote the conversion of naïve CD4+ T cells into Th17 cells [20,21].”
BackgroundPapa, A., Dato, M. T. D., Buonavolontà, P., Saracco, E., Salzano, A. M., & Casale, B. (2020) · Anesthesiology and Pain Medicine · doi:10.5812/aapm.104151 · Cited by 12
“High levels of IL-6, IL-23, and TGF-β would induce the differentiation of helper T cells from type T0 into Th17 (2).”
BackgroundInfluentialWang, W. W., Yu, H. W., Zhang, B., Pan, Y. L., & Shao, S. W. (2020) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-020-06274-3 · Cited by 13
“Epithelial cells, fibroblasts and endothelial cells are the major targets of IL-17A [32].”
BackgroundIs workaholism associated with inflammatory response? The moderating role of work engagement
Girardi, D., CARLO, A. D., Corso, L. D., Andreassen, C. S., & Falco, A. (2019) · Padua Research Archive (University of Padova) · doi:10.4473/tpm26.2.9 · Cited by 16
Wang, X., Sheng, Y., Guan, J., Zhang, F., & Lou, C. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.117764 · Cited by 12
Advances in understanding the role of interleukins in pulmonary fibrosis (Review)
He, Y., Shen, X., Zhai, K., & Nian, S. (2024) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2024.12775 · Cited by 11
He, W., Yang, H.-C., Yang, X., Huang, J., & Wu, Z. (2025) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2024.2445900 · Cited by 11
Chen, S., Fu, P., Rastegar‐Kashkooli, Y., Zhu, L., Zong, Y., Huang, M., Gao, C., Wang, J., Zhang, J., Wang, J., et al. (2025) · Stroke · doi:10.1161/strokeaha.124.048507 · Cited by 11
“4,38 It has been known that RANTES and IL-17 are mainly secreted by activated CD4 + T cells, 39,40 while IFN-γ and XCL1 are mainly produced by activated CD8 + T cells.”
Does Interleukin-17 Play the Villain in Nonalcoholic Steatohepatitis?
Kisseleva, T. (2013) · Hepatology · doi:10.1002/hep.26955 · Cited by 11
“IL-17 signaling plays a critical role in mediating autoimmunity, such as the autoimmune inflammatory diseases psoriasis and rheumatoid arthritis that respond to anti-IL-17 biological therapies.(2) More recently, IL-17 has been implicated in liver, lung, and skin fibrosis, and in tumorigenesis.”
BackgroundContributions of neutrophils to the adaptive immune response in autoimmune disease
Pietrosimone, K. M., & Liu, P. (2015) · World Journal of Translational Medicine · doi:10.5528/wjtm.v4.i3.60 · Cited by 11
“The reciprocal signaling between Th17 cells and neutrophils causes accumulation and activation of these cells, cultivating an inflammatory microenvironment in the joint[58,60,66].”
BackgroundTerapias antiinflamatorias para la enfermedad cardiovascular: vías de señalización y mecanismos
Martínez‐Hervás, S., & Navarro, H. G. (2019) · Revista Española de Cardiología · doi:10.1016/j.recesp.2019.02.022 · Cited by 11
Investigation of IL‐17A Serum Levels in Patients with Nonmelanoma Skin Cancer
Ghahartars, M., Sedaghat, F., Khajavi, E., Nejat, A., Malekzadeh, M., Ghaderi, A. A., & Fattahi, M. J. (2021) · Dermatology Research and Practice · doi:10.1155/2021/5540163 · Cited by 11
“IL-17A antibodies have already been found to be nontoxic and successful in treating various chronic in-flammatory conditions such as rheumatoid arthritis, ankylosing spondylitis, inflammatory bowel disease (IBD), and psoriasis [36–39].”
Liu, Y., Chen, X., Wang, F., Cheng, B., & Zhou, G. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108778 · Cited by 13
Zou, H., Yang, Y., Shi, Z., Wu, X., Liu, R., Yu, A., & Chen, H.-W. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106324 · Cited by 16
Lin, S. J.-H., Helm, E. T., Gabler, N. K., & Burrough, E. R. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1042815 · Cited by 12
“IL-17A is a signature cytokine of type 17 T helper (Th17) cells, which is known to be crucial in immune surveillance and innate immunity at mucosal and barrier surfaces (Miossec and Kolls, 2012; Song et al., 2016).”
BackgroundGege, C. (2015) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2015.1065816 · Cited by 11
“In addition, TH17 cells or their products have been shown to be associated with the pathology of a variety of human inflammatory and autoimmune disorders including rheumatoid arthritis, psoriasis, multiple sclerosis, Crohn’s disease and asthma [3,4].”
BackgroundAkkurt, Z. M., Uçmak, D., Türkçü, G., Yüksel, H., Yildiz, K., & Arıca, M. (2014) · Central European Journal of Immunology · doi:10.5114/ceji.2014.45950 · Cited by 11
“The effectiveness of these agents in the treatment of EM may be investigated [39].”
BackgroundWang, K., Jin, F., Zhang, Z., & Sun, X. (2016) · Medical Science Monitor · doi:10.12659/msm.900842 · Cited by 11
“Th17, a new separated T cell subset, secrets IL-17 and other chronic inflammatory diseases and is closely related to autoimmune diseases [34].”
BackgroundKim, M. K., Jeong, J. S., Han, K., Baek, K. H., Song, K., & Kwon, H. (2018) · Scientific Reports · doi:10.1038/s41598-018-20573-0 · Cited by 11
Roles of IL-17A and IL-23 in the Pathogenesis of Ulcerative Colitis and Crohn’s Disease
Abdul-Hussein, S. S., Ali, E. N., Alkhalidi, N. M. F., Zaki, N. H., & Ad'hiah, A. H. (2021) · Iraqi Journal of Science · doi:10.24996/ijs.2021.62.8.5 · Cited by 11
“IL-17A is a proinflammatory cytokine and the main effector molecule that stimulates STAT3 (signal transducer and activator of transcription 3), which is involved in triggering strong immune responses during chronic inflammation [8].”
BackgroundDuan, X., Lv, J., Jiang, H., Zheng, K., & Chen, Y. (2022) · Genetics Research · doi:10.1155/2022/8560831 · Cited by 11
“*17 cells are considered as major inducers of autoimmunity, leading to tissue inflammation [7].”
BackgroundAcuff, N. V., Li, X., Kirkland, R. A., Nagy, T., & Watford, W. T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119885 · Cited by 12
“Together, Th17 effector cytokines are required for the clearance of extracellular bacterial and fungal infections, but dysregulated Th17 responses have also been implicated in the development of autoimmune diseases, including multiple sclerosis, rheumatoid arthritis and inflammatory bowel diseases (reviewed in [25]).”
BackgroundIncrease risk of allergic diseases in patients with ankylosing spondylitis
Chang, W.-P., Kuo, C.-N., Kuo, L., Wang, Y., Perng, W., Kuo, H., & Wei, J. C. (2016) · Medicine · doi:10.1097/md.0000000000005172 · Cited by 11
“The difference between the groups were considered significant if two sided P values were smaller than 0.05.”
BackgroundInfluentialFei, X., Zhang, P., Zhang, X., Zhang, G.-Q., Bao, W., Zhang, Y., Zhang, M., & Zhou, X. (2017) · Inflammation · doi:10.1007/s10753-017-0523-7 · Cited by 11
“IL8 [7, 34] and IL-17A [43] contribute to the recruitment of neutrophils.”
BackgroundRosado‐Sánchez, I., Herrero-Fernández, I., Tarancón‐Díez, L., Moreno, S., Iribarren, J. A., Dalmau, D., Vera, F. J., Leal, M., & Pacheco, Y. M. (2017) · Journal of Infection · doi:10.1016/j.jinf.2017.10.010 · Cited by 11
Li, M., Yang, Y., Xu, C., Wei, J., Liu, Y., Cun, X., Yu, Q., Tang, X., Yin, S., Zhang, Z., et al. (2019) · The AAPS Journal · doi:10.1208/s12248-018-0289-3 · Cited by 11
“T helper 17 (TH 17) cells play important roles in inflammation and autoimmune diseases and secrete TH17 effector cytokines such as IL17a, which in turn induce the secretion of proinflammatory cytokines such as IL-6, thereby regulating tissue inflammation, and damage (46).”
Huang, H.-M., Pai, M., Yeh, S., & Hou, Y.-C. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02615-2 · Cited by 12
Navigating the diverse immune landscapes of psoriatic arthritis
Ritchlin, C. T. (2021) · Seminars in Immunopathology · doi:10.1007/s00281-021-00848-x · Cited by 11
Pan, N., Liu, B., Bao, X., Zhang, H. C., Sheng, S., Liang, Y., Pan, H., & Wang, X. (2021) · Vaccines · doi:10.3390/vaccines9090984 · Cited by 12
Clinical Features and Early Recognition of 242 Cases of Autoimmune Encephalitis
Yang, M., & Lian, Y. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2021.803752 · Cited by 14
“As is well-known, Interleukin-17 (IL-17) plays an important role in the rheumatic immune system (27).”
BackgroundShuto, T. (2013) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.13-00208 · Cited by 11
Zhou, F., Qiu, L., Cheng, L., Wang, M., Li, J., Sun, M.-H., Yang, Y.-J., Wang, J.-C., Li, J., Wang, Y.-N., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11616 · Cited by 11
“IL-17 is the founding member of the cytokine family with six members (IL-17A, IL-17B, IL-17C, IL-17D, IL-17E, and IL-17F), it is mainly produced by the activated T cells, such as the T-helper 17 (Th17) cells, natural killer cells, mast cells and neutrophils, and it plays a crucial role in human immune system [7].”
BackgroundThymosin β4 Alleviates Autoimmune Dacryoadenitis via Suppressing Th17 Cell Response
Zhao, X., Li, N., Yang, N., Mi, B., Dang, W., Sun, D., Ma, S., Nian, H., & Wei, R. (2023) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.64.11.3 · Cited by 10
Curren, B. F., Ahmed, T., Rashid, R. B., Sebina, I., Sikder, M. A. A., Howard, D. R., Alorro, M., Ullah, M. A., Bissell, A., Rahman, M. M., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114974 · Cited by 10
Liu, Q., Zhang, Y., Duan, R., Li, W., Hou, X., Chen, Y., Li, B., & Yang, T. (2025) · Respiratory Research · doi:10.1186/s12931-025-03303-9 · Cited by 10
“KEGG pathway enrichment analysis of DEGs showed that IL-17, TNF and cytokine − cytokine receptor interaction were the top three pathways, which were reported to be closely associated with inflammation and immunity [23, 24].”
Peng, Y., Demidchik, V. V., Li, Y., Lei, X., Lin, Y., Zhang, Y., & Zhou, D. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.112014 · Cited by 10
Zou, C., Cao, Y., Liu, J., Dong, X., Bi, J., Guo, W., & Fu, S. (2025) · Animals and zoonoses. · doi:10.1016/j.azn.2025.07.004 · Cited by 10
Kuret, T., Frank‐Bertoncelj, M., Lakota, K., Žigon, P., Thallinger, G., Kopitar, A. N., Čučnik, S., Tomšič, M., Hočevar, A., & Sodin‐Šemrl, S. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.827095 · Cited by 11
“This might be associated with the primary effect of leflunomide inhibiting T-lymphocyte proliferation (29, 38) and thus inhibiting the IL-23-driven polarization toward the Th17 lineage (37, 39).”
BackgroundTang, X., Wang, C., Wang, L., Ren, F., Kuang, R., Li, Z., Han, X., Chen, Y., Chen, G., Wu, X., et al. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.03.017 · Cited by 10
“first reported the structures of myrothecisin C (2) and myrothecisin D (3) and demonstrated their weak aglucosidase inhibitory activity (IC50 values of 58 and 200 mmol/L, respectively).”
BackgroundLei, H., Su, H., Cao, L., Zhou, X., Liu, Y., Li, Y., Song, X., Wang, Y., & Guan, Q. (2024) · Analytical Biochemistry · doi:10.1016/j.ab.2024.115629 · Cited by 10
Giacomini, F., Rho, H. S., Eischen-Loges, M. J., Birgani, Z. N. T., van Blitterswijk, C., van Griensven, M., Giselbrecht, S., Habibović, P., & Truckenmüller, R. K. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202401815 · Cited by 10
Tumorigenic Th17 cells in oncogenic Kras-driven and inflammation-accelerated lung cancer
Chang, S. H. (2014) · OncoImmunology · doi:10.4161/21624011.2014.955704 · Cited by 10
“IL-17 and Th17 cells have been promising targets for treating autoimmune diseases.(3) The intricate relationship between inflammation and cancer offers an opportunity to evaluate the functions of IL-17 and Th17 cells in tumor immunity.”
Background
Metadata
- Authors
- Miossec, P., & Kolls, J. K.
- Affiliations
- Lyon 1 Université (FR)
- University of Pittsburgh (US)
- Corresponding author
- Miossec, Pierre
- Kolls, Jay K.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2012-10
- Volume
- 11
- Issue
- 10
- Pages
- 763-776
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2022917731
- Cited by
- 1,414
- References
- 169
- Citations by year
- 2026: 74 · 2025: 104 · 2024: 137 · 2023: 101 · 2022: 121 · 2021: 129 · 2020: 97 · 2019: 91 · 2018: 67 · 2017: 114 · 2016: 100 · 2015: 109 · 2014: 97 · 2013: 72 · 2012: 1
- FWCI
- 8.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Institut Universitaire de France
- Institut Mérieux
- National Heart, Lung, and Blood Institute (R37HL079142)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Keywords
- IL-17, Th17 cells, IL-17 inhibitors, IL-23, IL-17 receptor A, psoriasis, rheumatoid arthritis, ankylosing spondylitis, chronic inflammation, autoimmunity, biologic therapy, IL-17A
- MeSH terms
- Animals, Chronic Disease, Humans, Inflammation, Drug Delivery Systems, Interleukin-17, Receptors, Interleukin-17, Th17 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.